Literature DB >> 12822834

Reproducibility of the lactate stress test.

Josef Finsterer1.   

Abstract

Although the lactate stress test has been shown to be a powerful tool to screen for respiratory chain disorders, little is known about the reproducibility of this test. The aim of the present study was thus to look for the reliability of the lactate stress test in disease controls and patients with primary respiratory chain disorders. In 23 patients with respiratory chain disorder, 16 women and 7 men, aged 36-81 years, and 18 disease controls, 5 women and 18 men, aged 37-70 years, the lactate stress test was carried out when respiratory chain disorder was suspected for the first time and at the first follow-up. The sensitivity of the first lactate stress test was 81% and the specificity 72%. The sensitivity of the second lactate stress test was 74% and the specificity 61%. The reproducibility of the lactate stress test was 65% in patients with respiratory chain disorders and 78% in disease controls. In conclusion, this study shows that the sensitivity, specificity, and reproducibility of the lactate stress test is high enough to warrant its application as a reliable, supplementary method to search for respiratory chain disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12822834     DOI: 10.1023/a:1023867104002

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  19 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  L P Rowland; N A Shneider
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  Does the patient have a mitochondrial encephalomyopathy?

Authors:  S DiMauro; E Bonilla; D C De Vivo
Journal:  J Child Neurol       Date:  1999-11       Impact factor: 1.987

3.  Phenotype variability in 130 adult patients with respiratory chain disorders.

Authors:  J Finsterer; C Jarius; H Eichberger
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

4.  [Standardized bicycle ergometry test in mitochondrial myopathies. Indications, interferences and clinical parameters].

Authors:  A Chan; R Gold; S Arp; K W Pflughaupt; K V Toyka; H Reichmann
Journal:  Nervenarzt       Date:  1998-06       Impact factor: 1.214

5.  Diagnostic yield of the lactate stress test in 160 patients with suspected respiratory chain disorder.

Authors:  J Finsterer; I Obermann; E Milvay
Journal:  Metab Brain Dis       Date:  2000-09       Impact factor: 3.584

6.  [Lactate and pyruvate blood levels in the diagnosis of mitochondrial myopathies].

Authors:  S Zierz; S Meessen; F Jerusalem
Journal:  Nervenarzt       Date:  1989-09       Impact factor: 1.214

7.  Muscle fatigue, lactate, and pyruvate in mitochondrial myopathy with progressive external ophthalmoplegia.

Authors:  R Dengler; K Wohlfarth; S Zierz; M Jobges; M Schubert
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

8.  In vivo functional investigations of lactic acid in patients with respiratory chain disorders.

Authors:  G Touati; O Rigal; A Lombès; P Frachon; M Giraud; H Ogier de Baulny
Journal:  Arch Dis Child       Date:  1997-01       Impact factor: 3.791

9.  Screening for mitochondrial cytopathies: the sub-anaerobic threshold exercise test (SATET).

Authors:  L Nashef; R J Lane
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

10.  The relationship of plasma catecholamine and lactate during anaerobic threshold exercise in mitochondrial myopathies.

Authors:  G Siciliano; M Renna; M L Manca; C Prontera; G Zucchelli; E Ferrannini; L Murri
Journal:  Neuromuscul Disord       Date:  1999-10       Impact factor: 4.296

View more
  2 in total

1.  Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression.

Authors:  Yuan-Jin Zhang; Dong-Sheng Fan
Journal:  Chin Med J (Engl)       Date:  2016-01-05       Impact factor: 2.628

2.  Phenotypic Heterogeneity of the m.14459G>A Mutation.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Child Neurol Open       Date:  2017-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.